Is Arcturus Therapeutics Holdings Inc. (ARCT) a Buy, Sell, or Hold?
NASDAQ : ARCT
Arcturus Therapeutics Holdings Inc. — Institutional Ownership
$6 USD
$0.24 (4.17%)
- Volume
- 249.61K
- Average Volume
- 475.6K
- Market Capitalization
- $170.54M
- P/E Ratio
- -2.12
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $24.17
- Year Low
- $5.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.31
Institutional Ownership Summary
Institutional Ownership %
10.96%
Investors Holding
32
change: -98 | last: 130
Increased Positions
18
change: -56 | last: 74
Reduced Positions
8
change: -29 | last: 37
New Positions
5
change: -22 | last: 27
Sold Positions
98
change: 73 | last: 25
Total Calls
1321
Total Puts
-
Put-Call Ratio
0.00
change: -79.7883 | last: 0.7979
Total Invested
20.93M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-07 | ARK Investment Management LLC | 2.95M | 10.37% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Balyasny Asset Management L.P. | - | 0.00% |
| 2026-02-03 | ARK Investment Management LLC | 2.61M | 9.19% |
| 2026-01-08 | Federated Hermes, Inc. | 3.3M | 11.63% |
| 2025-11-14 | Balyasny Asset Management L.P. | 2.18M | 8.04% |
| 2025-11-13 | Amova Asset Management Americas, Inc. | 1.95M | 7.20% |
| 2025-10-27 | Sumitomo Mitsui Trust Group, Inc. | 1.95M | 7.20% |
| 2025-07-30 | ARK Investment Management LLC | 1.72M | 6.32% |
| 2025-07-29 | The Vanguard Group | 1.81M | 6.67% |
| 2025-05-12 | Nikko Asset Management Americas, Inc. | 1.93M | 7.10% |
| 2025-04-25 | Sumitomo Mitsui Trust Group, Inc. | 1.93M | 7.10% |
| 2025-04-23 | BlackRock, Inc. | 2.1M | 7.80% |
| 2025-02-05 | STATE STREET CORPORATION | 1.33M | 4.90% |
| 2024-11-08 | Nikko Asset Management Americas, Inc. | 2.32M | 8.56% |
| 2024-11-05 | Nikko Asset Management Co., Ltd. (“NAM”) | 2.32M | 8.56% |
| 2024-11-05 | Sumitomo Mitsui Trust Group, Inc. (“SMTG”) | 2.32M | 8.56% |
| 2023-02-09 | The Vanguard Group - 23-1945930 | 1.45M | 5.46% |
| 2022-04-11 | STATE STREET CORPORATION | 3.22M | 12.20% |
| 2022-04-11 | SSGA FUNDS MANAGEMENT, INC. | 2.78M | 10.52% |
| 2022-02-14 | Thomas R. Donahue | 3.69M | 14.02% |
| 2022-02-14 | 52-0556948 | 15039.0 | 0.00% |
| 2022-02-14 | Voting Shares Irrevocable Trust | 3.69M | 14.02% |
| 2022-02-14 | Federated Hermes, Inc. | 3.69M | 14.02% |
| 2022-02-14 | Nikko Asset Management Americas, Inc. | 1.36M | 5.15% |
| 2022-02-14 | J. Christopher Donahue | 3.69M | 14.02% |
| 2022-02-14 | Rhodora J. Donahue | 3.69M | 14.02% |
| 2022-02-15 | Arcturus Therapeutics Holdings Inc. | 843.75K | 12.38% |
| 2022-02-11 | STATE STREET CORPORATION | 2.06M | 7.80% |
| 2022-02-11 | SSGA FUNDS MANAGEMENT, INC. | 1.64M | 6.22% |
| 2022-02-09 | ARK Investment Management LLC | 2.47M | 9.38% |
| 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) | 1.36M | 5.14% |
| 2022-02-04 | Nikko Asset Management Co., Ltd. (“NAM”) | 1.36M | 5.14% |
| 2022-02-03 | (1) BlackRock, Inc. | 1.76M | 6.70% |
| 2021-11-09 | ARK Investment Management LLC | 2.85M | 10.84% |
| 2021-10-26 | 27-2546083 | 1.2M | 4.60% |
| 2021-08-12 | 27-2546083 | 1.4M | 5.30% |
| 2021-02-16 | Bihua Chen | - | 0.00% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | - | 0.00% |
| 2021-02-16 | Cormorant Asset Management, LP | - | 0.00% |
| 2021-02-16 | ARK Investment Management LLC | 3.96M | 15.31% |
| 2021-02-16 | Cormorant Global Healthcare GP, LLC | - | 0.00% |
| 2021-02-16 | 52-0556948 | 1.42M | 5.40% |
| 2021-02-12 | HealthCor Therapeutics Master Fund, L.P. | - | 0.00% |
| 2021-02-12 | Arthur Cohen | - | 0.00% |
| 2021-02-12 | Joseph Healey | - | 0.00% |
| 2021-02-12 | HealthCor Sanatate Offshore Master Fund, L.P. | - | 0.00% |
| 2021-02-12 | HealthCor Associates, LLC | - | 0.00% |
| 2021-02-12 | HealthCor Offshore Master Fund, L.P. | - | 0.00% |
| 2021-02-12 | HealthCor Offshore GP, LLC | - | 0.00% |
| 2021-02-12 | HealthCor Group, LLC | - | 0.00% |
| 2021-02-12 | HealthCor Offshore II GP, LLC | - | 0.00% |
| 2021-02-12 | HealthCor Therapeutics GP, LLC | - | 0.00% |
| 2021-02-12 | HealthCor Management, L.P. | - | 0.00% |
| 2021-02-02 | (1) BlackRock, Inc. | 1.78M | 6.90% |
| 2021-01-08 | Federated Hermes, Inc. | 3.45M | 13.35% |
| 2021-01-08 | J. Christopher Donahue | 3.45M | 13.35% |
| 2021-01-08 | Rhodora J. Donahue | 3.45M | 13.35% |
| 2021-01-08 | Voting Shares Irrevocable Trust | 3.45M | 13.35% |
| 2021-01-08 | Thomas R. Donahue | 3.45M | 13.35% |
| 2020-12-10 | 27-2546083 | 2.2M | 9.00% |
| 2020-10-09 | ARK Investment Management LLC | 2.5M | 10.23% |
| 2020-09-11 | HealthCor Management, L.P. | 1.58M | 6.50% |
| 2020-09-11 | HealthCor Therapeutics GP, LLC | 90170.0 | 0.40% |
| 2020-09-11 | HealthCor Sanatate Offshore Master Fund, L.P. | 447.4K | 1.80% |
| 2020-09-11 | HealthCor Therapeutics Master Fund, L.P. | 90170.0 | 0.40% |
| 2020-09-11 | HealthCor Offshore II GP, LLC | 447.4K | 1.80% |
| 2020-09-11 | Joseph Healey | 1.58M | 6.50% |
| 2020-09-11 | Arthur Cohen | 1.58M | 6.50% |
| 2020-09-11 | HealthCor Group, LLC | 830.27K | 3.40% |
| 2020-09-11 | HealthCor Offshore GP, LLC | 292.7K | 1.20% |
| 2020-09-11 | HealthCor Offshore Master Fund, L.P. | 292.7K | 1.20% |
| 2020-09-11 | HealthCor Associates, LLC | 1.58M | 6.50% |
| 2020-05-22 | 27-2546083 | 3M | 14.60% |
| 2020-04-27 | Cormorant Global Healthcare GP, LLC | 1.08M | 5.45% |
| 2020-04-27 | Cormorant Global Healthcare Master Fund, LP | 1.08M | 5.45% |
| 2020-04-27 | Bihua Chen | 1.14M | 5.76% |
| 2020-04-27 | Cormorant Asset Management, LP | 1.14M | 5.76% |
ARCT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6.13 | 27.39M | $167.88M | $230.91M | $25M | -$38.03M |
| 2024-12-31 | $16.97 | 27M | $458.19M | $237.03M | $28.55M | $249.71M |
| 2023-12-31 | $31.53 | 26.63M | $839.58M | $292M | $30.22M | $577.79M |
| 2022-12-31 | $16.96 | 26.44M | $448.51M | $391.88M | $94.76M | $151.38M |
| 2021-12-31 | $37.01 | 26.32M | $973.99M | $370.49M | $69.15M | $672.65M |
| 2020-12-31 | $43.38 | 20.3M | $880.83M | $462.9M | $20.75M | $438.69M |
| 2019-12-31 | $10.87 | 12.07M | $131.19M | $71.35M | $20.67M | $80.51M |
| 2018-12-31 | $4.53 | 10.07M | $45.61M | $36.71M | $9.91M | $18.81M |
| 2017-12-31 | $7.99 | 3.09M | $24.67M | $24.96M | -$ | -$299.87K |
| 2016-12-31 | $14.70 | 3.94M | $57.88M | $2.3M | $133K | $55.71M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7.72 | 28.42M | $219.41M | $211.38M | $23.99M | $32.02M |
| 2025-12-31 | $6.13 | 27.39M | $167.88M | $230.91M | $25M | -$38.03M |
| 2025-09-30 | $18.43 | 27.19M | $501.07M | $180.36M | $25.99M | $346.7M |
| 2025-06-30 | $13.01 | 27.13M | $352.95M | $196.47M | $26.96M | $183.45M |
| 2025-03-31 | $10.59 | 27.11M | $287.06M | $216.95M | $42.66M | $112.77M |
| 2024-12-31 | $16.97 | 27M | $458.19M | $237.03M | $28.55M | $249.71M |
| 2024-09-30 | $23.21 | 27.06M | $628.11M | $237.18M | $29.42M | $420.35M |
| 2024-06-30 | $23.66 | 26.97M | $638.04M | $315.33M | $30.88M | $353.59M |
| 2024-03-31 | $33.08 | 26.88M | $889.16M | $288.4M | $31.92M | $632.68M |
| 2023-12-31 | $31.53 | 26.63M | $839.58M | $292M | $30.22M | $577.79M |
| 2023-09-30 | $25.55 | 26.57M | $678.97M | $311.92M | $51.22M | $418.27M |
| 2023-06-30 | $28.68 | 26.56M | $761.83M | $323.47M | $32.2M | $470.56M |